Details for United Kingdom Supplementary Protection Certificate: SPC/GB15/022
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2201840 | SPC/GB15/022 | United Kingdom | CORRECTION OF GRANT INFORMATION ON SUPPLEMENTARY PROTECTION CERTIFICATE APPLICATIONS APPLICANT: PHARMACYCLICS LLC995 EAST ARQUES AVENUE, SUNNYVALE, CA 94085, UNITED STATES OF AMERICA PRODUCT: IBRUTINIB, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF PRODUCT TYPE: MEDICINALAUTHORISED: UK EU/1/14/945 23 OCTOBER 2014 AUTHORISED EXTENSION: PATENT NO: EP2201840TITLE: INHIBITORS OF BRUTON'S TYROSINE KINASESPC NO: SPC/GB15/022DATE GRANTED: 15 OCTOBER 2020 MAXIMUM PERIOD EXPIRES ON: 22 OCTOBER 2029*CORRECTION OF GRANT DETAILS IN JOURNAL NUMBER 6860 DATED 11 NOVEMBER 2020 TO INCLUDE MAXIMUM EXPIRY DETAILS. | ⤷ Start Trial |
